SCHEMBL28426760

SCHEMBL28426760

COc1nnc2cc(OCC3CCN(S(N)(=O)=O)CC3)ccc2c1Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ F2 P00734 2/20 0.40
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ CA14 Q9ULX7 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CYP19A1 P11511 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30646047 0.77 PDGFRA (0.42) SIGMAR1SMN1; SMN2HTTRECQLCA1
SCHEMBL29111064 0.77 PDGFRA (0.42) SIGMAR1SMN1; SMN2HTTRECQLCA1
SCHEMBL29111047 0.73 MEN1 (0.44) HTTALDH1A1LMNAMAPTNPSR1
SCHEMBL30646027 0.73 MEN1 (0.44) HTTALDH1A1LMNAMAPTNPSR1
SCHEMBL27935616 0.70 SIGMAR1 (0.67) SIGMAR1SMN1; SMN2HTTRECQLF2
SCHEMBL27950117 0.66 SIGMAR1 (0.62) SIGMAR1SMN1; SMN2HTTRECQLALDH1A1
SCHEMBL1674342 0.66 SIGMAR1 (0.73) SIGMAR1SMN1; SMN2F2ALDH1A1
SCHEMBL30646062 0.65 EGFR (0.44) —
SCHEMBL27935609 0.64 SIGMAR1 (0.70) SIGMAR1RECQLF2ALDH1A1MAPT
SCHEMBL2566683 0.63 SIGMAR1 (0.78) SIGMAR1SMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111253385-A Heterocyclic compound, preparation method and application 遵义医科大学珠海校区 2020-06-09 — — CN disclosed
Send feedback